Anti-CD19 (hBU12)-Mc-MMAF ADC (SGN-19A) (CAT#: ADC-L034)

This ADC product is composed of an anti-CD19 antibody (clone hBU12) conjuagated via a Mc linker to MMAF (hBU12-mc-MMAF). It has demonstrated a response in B cell lymphoma treatment by a MOA (Mechanism of Action) of Depolymerize Microtubules.

Specific Inquiry
  • Gene Expression
  • Datasheet
  • MSDS
  • COA
Normal Tissue
RNA Expression

Specifications

  • Antibody Overview
  • Humanized IgG1k antibody hBU12 (Anti-CD19)
  • Clone
  • hBU12
  • Antibody Conjugation
  • Humanized
  • Linker
  • Mc (maleimidocaproyl)
  • Linker Class/Description
  • Class: Noncleavable linkers
    Description: Noncleavable linker is considered noncleavable-meaning linker cleavage, and payload release does not depend on the differential properties between the plasma and some cytoplasmic compartments. Instead, the release of the cytotoxic drug is postulated to occur after internalization of the ADC via antigen-mediated endocytosis and delivery to lysosomal compartment, where the antibody is degraded to the level of amino acids through intracellular proteolytic degradation.
  • Drug
  • MMAF (Monomethyl auristatin F)
  • Drug Class/Description
  • Auristatins are water-soluble dolastatin analogs of dolastatin 10. Dolastatin 10 belongs to dolastatin family and it can powerfully bind to tubulin, thus inhibiting polymerization mediated through the binding to the vinca alkaloid binding domain, and causes cell to accumulate in metaphase arrest.

Target

  • Introduction
  • Lymphocytes proliferate and differentiate in response to various concentrations of different antigens. The ability of the B cell to respond in a specific, yet sensitive manner to the various antigens is achieved with the use of low-affinity antigen receptors. This gene encodes a cell surface molecule which assembles with the antigen receptor of B lymphocytes in order to decrease the threshold for antigen receptor-dependent stimulation.
  • Alternative Names
  • B4; CVID3

Related Resources

  • Related Diseases

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "Clone hBU12"

See other products for "CD19"

Select a product category from the dropdown menu below to view related products.
Please select product type
Humanized Antibody Immunotoxin Chimeric Antibody Human Antibody Mouse Antibody Fc Glycosylation Low- or Non-fucosylated Oligosaccharide Chicken IgY Antibody Neutralizing Antibody Blocking Antibody Rabbit Monoclonal Antibody Recombinant Antibody Fab Fragment Antibody ADCC Enhanced Antibody scFv Fragment Antibody
CAT Product Name Application Type
TAB-891 Humanized Anti-CD19 Recombinant Antibody (clone Denintuzumab) ELISA, FC, IP, FuncS, IF, Neut, ICC Humanized IgG1, κ
TAB-1612CL-S(P) Human Anti-CD19 Recombinant Antibody; scFv Fragment (TAB-1612CL-S(P)) Depletion, FuncS Humanized scFv
TAB-1625CL-S(P) Anti-Human CD19 Recombinant Antibody scFv Fragment (396) Depletion, ELISA Humanized antibody
TAB-1612CL-F(E) Human Anti-CD19 Recombinant Antibody; Fab Fragment (TAB-1612CL-F(E)) Depletion, FuncS Humanized Fab
TAB-431CQ Anti-Human CD19 Recombinant Antibody ELISA, IHC, FC, IP, IF, FuncS IgG1, κ

Customer Reviews and Q&As

Submit a review or a question

There are currently no Customer reviews or questions for ADC-L034. Click the button above to contact us or submit your feedback about this product.

Popular products with customers


For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

  • 0
  • 0
Cart
    Go to compare

    Go to compare